玻璃体腔注射傲迪适和阿柏西普治疗糖尿病视网膜病变黄斑囊样水肿疗效及对视野灰度值、黄斑厚度和炎症因子的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(81801381);


Efficacy of intravitreal injection of ozurdex and aflibercept on cystoid macular edema caused by diabetic retinopathy and its influence on visual field gray value,macular thickness and inflammatory factors
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:比较玻璃体腔注射傲迪适与阿柏西普治疗糖尿病性视网膜病变(DR)所致黄斑囊样水肿(CME)的疗效及对视野灰度值、黄斑厚度和炎症因子的影响。方法:选取92例(164眼)糖尿病视网膜病变黄斑囊样水肿患者作为研究对象,根据治疗方法不同将患者分为傲迪适组(n=45,85眼)和阿柏西普组(n=47,79眼),傲迪适组注射傲迪适0.7 mg;阿柏西普组注射阿柏西普2 mg。治疗3个月后评估疗效、视力、视野、黄斑参数及炎症、生化指标。记录并比较治疗期间两组患者不良事件发生情况。结果:傲迪适组治疗有效率高于阿柏西普组(P<0.05),光敏感度高于阿柏西普组(P<0.05),BCVA LogMAR值、视野灰度值、黄斑厚度(CRT)、黄斑总体积(TMV)、白细胞介素-1β(IL-1β)、白细胞介素-23(IL-23)、单核细胞趋化因子蛋白-1(MCP-1)水平低于阿柏西普组(P<0.05);阿柏西普组血管内皮生长因子(VEGF)、人基质细胞衍生因子1(SDF-1)水平低于傲迪适组(P<0.05)。两组不良事件总发生率无统计学差异(P>0.05)。结论:与阿柏西普比较,傲迪适治疗DR所致CME疗效更佳,视力恢复快,视野改善明显,炎症反应减轻,但抑制新生血管效果略逊于阿柏西普。

    Abstract:

    Objective:To compare the efficacy of intravitreal injection of ozurdex and aflibercept in the treatment of cystoid mac-ular edema(CME)caused by diabetic retinopathy(DR)and its influence on visual field gray value,macular thickness and inflamma-tory factors.Methods:The case data of 92 patients(164 eyes)with CME caused by DR were collected,and the above patients were di-vided into ozurdex group(n=47,79 eyes)and aflibercept group(n=45,85 eyes)by treatment methods.The ozurdex group was given injection of ozurdex(0.7 mg),while the aflibercept group was given injection of aflibercept(2 mg).The efficacy,visual acuity,visual field,macular parameters,inflammation and biochemical indexes were evaluated after 3 months of treatment,and the incidence rates of adverse events in the two groups during treatment were counted.Results:The efficacy in ozurdex group was better(P<0.05),and the light sensitivity was higher than that in aflibercept group(P<0.05),and the BCVA LogMAR value,visual field gray value,central macular thickness(CRT),total macular volume(TMV),interleukin-1 β(IL-1 β),interleukin-23(IL-23)and monocyte chemoattrac-tant protein-1(MCP-1)were lower(P<0.05).However,the levels of vascular endothelial growth factor(VEGF)and stromal cell-de-rived factor 1(SDF-1)in aflibercept group were lower(P<0.05).There were no significant differences in the total incidence rates of adverse events(P>0.05).Conclusion:Compared with aflibercept,ozurdex has better efficacy in the treatment of CME caused by DR.Ozurdex has rapid visual acuity recovery,obvious improvement of visual field and relieved inflammatory response,but the effect of inhib-iting neovascularization is slightly worse than that of aflibercept.

    参考文献
    相似文献
    引证文献
引用本文

王晓静;潘磊;宁美真;童念庭;.玻璃体腔注射傲迪适和阿柏西普治疗糖尿病视网膜病变黄斑囊样水肿疗效及对视野灰度值、黄斑厚度和炎症因子的影响[J].川北医学院学报,2025,40(4):425-429.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-24
  • 出版日期:
文章二维码